Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1172.9000 -25.80 (-2.15%)
NSE Jan 12, 2026 15:31 PM
Volume: 689.1K
 

logo
Aurobindo Pharma Ltd.
28 May 2025
1172.90
-2.15%
buy
by Axis Direct
Target: 1500 | Upside : 27.9%
Axis Direct
We maintain our BUY recommendation on Aurobindo Pharma with a TP of Rs 1,500/share.
 
Aurobindo Pharma Ltd.'s price crossed below 50Day SMA today
More from Aurobindo Pharma Ltd.
Recommended
IPO wave continues as Amagi Media and Five SMEs open for subscription
| 12 Jan 2026, 06:40PM
Market closes higher, supported by reassuring comments from US Ambassador Sergio Gor on India-US trade ties
Trendlyne Marketwatch | 12 Jan 2026, 04:04PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
| 15 Jul 2020